Effect of Long-Term Administration of Nicorandil on Endothelial Function of the Radial Artery in Patients With Angina Undergoing Transradial Percutaneous Coronary Intervention
Restricted accessResearch articleFirst published online August, 2017
Effect of Long-Term Administration of Nicorandil on Endothelial Function of the Radial Artery in Patients With Angina Undergoing Transradial Percutaneous Coronary Intervention
We evaluated the effect of long-term administration of nicorandil on endothelial function of the radial artery in patients with angina undergoing elective transradial coronary intervention (TRI). A total of 127 patients were randomly assigned to nicorandil (standard medication plus nicorandil 5 mg twice daily, n = 64) or control group (standard medication except nicorandil, n = 63) immediately after TRI procedure. Radial artery diameter (RAD), flow-mediated dilation (FMD), and nitroglycerin-mediated dilation (NMD) of radial artery were measured 1 day before TRI as well as 1 day and 3 months after TRI by Ultrasound-Doppler. No significant difference was observed in the baseline RAD, FMD, and NMD between the 2 groups (all P > .05). In cannulated arm, at 3-month follow-up, RAD in nicorandil group was much larger than that in the control group (2.78 ± 0.27 mm vs 2.61 ± 0.30 mm, P = .001). Besides, FMD and NMD were much higher in nicorandil group than those in the control group (10.38% ± 2.43% vs 6.81% ± 1.86%; 15.94% ± 6.28% vs 10.46% ± 5.37%, respectively, all Ps < .001). In conclusion, long-term administration of nicorandil after TRI could improve the endothelial function of the cannulated radial artery.
RaoSVCohenMGKandzariDEBertrandOFGilchristIC. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Coll Cardiol. 2010;55(20):2187–2195.
2.
HamonMMehtaSStegPG. Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes. EuroIntervention. 2011;7(1):91–97.
3.
PandieSMehtaSRCantorWJ. Radial versus femoral access for coronary angiography/intervention in women with acute coronary syndromes: insights from the RIVAL trial (Radial Vs femorAL access for coronary intervention). JACC Cardiovasc Interv. 2015;8(4):505–512.
4.
JollySSYusufSCairnsJ. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377(9775):1409–1420.
5.
KarrowniWVyasAGiacominoB. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2013;6(8):814–823.
6.
MamasMANolanJde BelderMA; British Cardiovascular Intervention Society (BCIS) and the National Institute for Clinical Outcomes Research (NICOR). Changes in arterial access site and association with mortality in the United Kingdom: observations from a national percutaneous coronary intervention database. Circulation. 2016;133(17):1655–1667.
7.
BianchiRD’AciernoLCrisciM. From femoral to radial approach in coronary intervention: review of the literature and 6 years single-center experience [published online July 11, 2016]. Angiology. 2016. doi:10.1177/0003319716656714.
8.
YonetsuTKakutaTLeeT. Assessment of acute injuries and chronic intimal thickening of the radial artery after transradial coronary intervention by optical coherence tomography. Eur Heart J. 2010;31(13):1608–1615.
9.
YanZZhouYZhaoYZhouZYangSWangZ. Impact of transradial coronary procedures on radial artery function. Angiology. 2014;65(2):104–107.
10.
MamasMAFraserDGRatibK. Minimising radial injury: prevention is better than cure. EuroIntervention. 2014;10(7):824–832.
11.
ButurakATekturkBMDegirmenciogluA. Transradial catheterization may decrease the radial artery luminal diameter and impair the vasodilatation response in the access site at late term: an observational study. Heart Vessels. 2016;31(4):482–489.
12.
IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359(9314):1269–1275.
13.
HorinakaSYabeAYagiH. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) Study. Circ J. 2010;74(3):503–509.
14.
HirohataAYamamotoKHiroseE. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study. EuroIntervention. 2014;9(9):1050–1056.
15.
FanYWeiQCaiJ. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization. Heart Vessels. 2016. doi:10.1007/s00380-0 16-0809-y.
16.
SerizawaKYogoKAizawaKTashiroYIshizukaN. Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats. Cardiovasc Diabetol. 2011;10:105.
17.
BertrandOFDe LarochellièreRRodés-CabauJ; Discharge After Transradial Stenting of Coronary Arteries Study Investigators. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation. Circulation. 2006;114(24):2636–2643.
18.
CorrettiMCAndersonTJBenjaminEJ; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–265.
19.
AlleyHOwensCDGasperWJGrenonSM. Ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery in clinical research. J Vis Exp. 2014;22(92):e52070.
20.
SekiyaMSatoMFunadaJOhtaniTAkutsuHWatanabeK. Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis. J Cardiovasc Pharmacol. 2005;46(1):63–67.
21.
HuangFYHuangBTWangPJ. Gender disparity in the safety and efficacy of radial and femoral access for coronary intervention: a systematic review and meta-analysis. Angiology. 2016; 67(9):810–819.
22.
NakataTIkedaSKogaS. Impact of catheter sheath insertion into the radial artery on vascular endothelial function assessed by reactive hyperemia peripheral arterial tonometry. Int Heart J. 2015;56(5):489–494.
23.
WakeyamaTOgawaHIidaH. Intima-media thickening of the radial artery after transradial intervention. An intravascular ultrasound study. J Am Coll Cardiol. 2003;41(7):1109–1114.
24.
StegemannESansoneRStegemannBKelmMHeissC. Validation of high-resolution ultrasound measurements of intima-media thickness of the radial artery for the assessment of structural remodeling. Angiology. 2015;66(6):574–577.
25.
StaniloaeCSModyKPSanghviK. Histopathologic changes of the radial artery wall secondary to transradial catheterization. Vasc Health Risk Manag. 2009;5(3):527–532.
26.
PohlUHoltzJBusseRBassengeE. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension. 1986;8(1):37–44.
27.
JoannidesRHaefeliWELinderL. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91(5):1314–1319.
28.
HorinakaSKobayashiNYagiHMoriYMatsuokaH. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure. J Cardiovasc Pharmacol. 2006;47(5):629–635.
29.
ZhaoAPDongYFLiuWGuJSunXL. Nicorandil inhibits inflammasome activation and Toll-like receptor-4 signal transduction to protect against oxygen-glucose deprivation-induced inflammation in BV-2 cells. CNS Neurosci Ther. 2014;20(2):147–153.
30.
AizawaKTakahariYHigashijimaN. Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formation. J Pharmacol Sci. 2015;127(3):284–291.
31.
GloireGPietteJ. Redox regulation of nuclear post-translational modifications during NF-kappaB activation. Antioxid Redox Signal. 2009;11(9):2209–2222.
32.
MehrhofFBSchmidt-UllrichRDietzRScheidereitC. Regulation of vascular smooth muscle cell proliferation: role of NF-kappaB revisited. Circ Res. 2005;96(9):958–964.
33.
ZhangYQTianFZhouY. Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats. Cardiovasc Diabetol. 2016;15(1):62.
